СУЧАСНИЙ СТАН ВИВЧЕННЯ МЕЛАТОНІН-ЗАЛЕЖНИХ РОЗЛАДІВ ЕНЕРГЕТИЧНОГО ОБМІНУ (ОГЛЯД ЛІТЕРАТУРИ)
DOI:
https://doi.org/10.24061/1727-4338.XXIII.1.87.2024.12Ключові слова:
ожиріння, маса тіла, мелатонін, метаболізм, енергетичний обмінАнотація
Мета роботи – проаналізувати сучасний стан вивчення мелатонін-залежних
розладів енергетичного обміну.
Висновки. Згідно даних наукових літературних джерел при ожирінні та
метаболічному синдромі відзначається зниження рівня та порушення ритму
продукціїмелатоніну.Мелатонін є ефективним засобом корекції низкипатологічних
змін, що супроводжують розвиток ожиріння та порушення енергетичного обміну.
Посилання
Genario R, Cipolla- Neto J, Bueno A, Santos H. Melatonin
supplementation in the management of obesity and obesityassociated disorders: A review of physiological mechanisms
and clinical applications. Pharmacological Research [Internet].
[cited 2024 Feb 26];163:105254. Available from: https://www.
sciencedirect.com/science/article/abs/pii/S1043661820315620
doi: 10.1016/j.phrs.2020.105254
Guan Q, Wang Z, Cao J, Dong Yu, Chen Ya. Mechanisms
of Melatonin in Obesity: A Review. Int J Mol Sci [Internet].
[cited 2024 Feb 23];23(1):218. Available from: https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC8745381/pdf/ijms-23-00218.
pdf doi: 10.3390/ijms23010218
Pfeffer M, Korf HW, Wicht H. Synchronizing effects of melatonin
on diurnal and circadian rhythms. Gen Comp Endocrinol.
;258:215-21. doi: 10.1016/j.ygcen.2017.05.013
Keskin A, Acı R, Duran, U, Sugeçti S. Physiological and Antiobesity Effects of Melatonin and Niacin Supplements in Rat
Models Adem KESKIN1, Recai ACI2, Utku DURAN3, Serkan
SUGEÇTI4. Caucasian Journal of Science. 2021;8(1):27-37.
doi: 10.48138/cjo.934158
Ramirez AVG, Filho DR, de Sá LBPC. Melatonin and
its Relationships with Diabetes and Obesity: A Literature
Review. Curr Diabetes Rev. 2021;17(7): e07260184137.
doi: 10.2174/1573399816666200727102357
Cardinali DP, Hardeland R. Inflammaging, metabolic syndrome
and melatonin: a call for treatment studies. Neuroendocrinology.
;104(4):382-97. doi: 10.1159/000446543
Promsan S, Lungkaphin A. The roles of melatonin on kidney injury
in obese and diabetic conditions. Biofactors. 2020;46(4):531-49.
doi: 10.1002/biof.1637
Szewczyk- Golec K, Rajewski P, Gackowski M, MilaKierzenkowska C, Wesołowski R, Sutkowy P, et al. Melatonin
Supplementation Lowers Oxidative Stress and Regulates
Adipokines in Obese Patients on a Calorie- Restricted Diet.
Oxid Med Cell Longev [Internet]. 2017[cited 2024 Feb
;2017:8494107. Available from: https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC5632922/pdf/OMCL2017-8494107.pdf
doi: 10.1155/2017/8494107
Liu Z, Gan L, Luo D, Sun C. Melatonin promotes circadian rhythminduced proliferation through Clock/histone deacetylase 3/c- Myc
interaction in mouse adipose tissue. J Pineal Res. 2017;62(4).
doi: 10.1111/jpi.12383
Yemchenko YaA, Ishcheikin KYe, Kaidashev IP. Ozhyrinnia
ta porushennia tsyrkadnoho rytmu u khvorykh na psoriaz
[Obesity and circadian rhythm disorders in patients with
psoriasis]. Actual Problems of the Modern Medicine: Bulletin of
Ukrainian Medical Stomatological Academy. 2021;21(1):160-5.
doi: 10.31718/2077-1096.21.1.160 (in Ukrainian)
Lee JG, Woo YS, Park SW, Seog DH, Seo MK, Bahk WM.
The Neuroprotective Effects of Melatonin: Possible Role in
the Pathophysiology of Neuropsychiatric Disease. Brain Sci
[Internet]. 2019[cited 2024 Feb 21];9(10):285. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826722/pdf/
brainsci-09-00285.pdf doi: 10.3390/brainsci9100285
Pivonello C, Negri M, Patalano R, Amatrudo F, Montò T, Liccardi
A, et al. The role of melatonin in the molecular mechanisms
underlying metaflammation and infections in obesity: A narrative
review. Obes Rev [Internet]. 2022[cited 2024 Feb 26];23(3):
e13390. Available from: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC9285339/pdf/OBR-23-0.pdf doi: 10.1111/obr.13390
Gheban BA, Rosca IA, Crisan M. The morphological and
functional characteristics of the pineal gland. Med Pharm Rep.
;92(3):226-34. doi: 10.15386/mpr-1235
Rogero MM, Calder PC. Obesity, inflammation, toll-like receptor
and fatty acids. Nutrients [Internet]. 2018[cited 2024 Feb
;10(4):432. Available from: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC5946217/pdf/nutrients-10-00432.pdf doi: 10.3390/
nu10040432
Tan DX, Manchester LC, Reiter RJ. CSF generation by pineal gland
results in a robust melatonin circadian rhythm in the third ventricle
as an unique light/dark signal. Med Hypotheses. 2016;86:3-9.
doi: 10.1016/j.mehy.2015.11.018
Fujimori M, França EL, Morais TC, Fiorin V, de Abreu LC,
Honório- França AC. Cytokine and adipokine are biofactors
can act in blood and colostrum of obese mothers. Biofactors.
;43(2):243-50. doi: 10.1002/biof.1339
Cheng J, Yang HL, Gu CJ, Liu YK, Shao J, Zhu R, et al. Melatonin
restricts the viability and angiogenesis of vascular endothelial
cells by suppressing HIF-1α/ROS/VEGF. Int J Mol Med.
;43(2):945-55. doi: 10.3892/ijmm.2018.4021
Misyura KV, Manska KG. Osoblyvosti sekretsii melatoninu y
serotoninu u molodykh zhinok iz riznoiu masoiu tila ta yikh
vzaiemozv’iazok z rozvytkom insulinorezystentnosti [Features of
melatonin and serotonin secretion in young women with different
body weight and their relationship with the development of insulin
resistance]. International Journal of Endocrinology (Ukraine).
;15(6):443-52. doi: 10.22141/2224-0721.15.6.2019.185406
(in Ukrainian)
Alsharif KF, Hamad AA, Alblihd MA, Ali FAZ, Mohammed SA,
Theyab A, et al. Melatonin downregulates the increased hepatic
alpha- fetoprotein expression and restores pancreatic beta cells in
a streptozotocin- induced diabetic rat model: a clinical, biochemical,
immunohistochemical, and descriptive histopathological study.
Front Vet Sci [Internet]. 2023[cited 2024 Feb 23];10:1214533.
Available from: Available from: https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC10467430/pdf/fvets-10-1214533.pdf
doi: 10.3389/fvets.2023.1214533
Chojnacki C, Walecka- Kapica E, Błońska A, Winczyk K,
Stępień A, Chojnacki J. Serotonin and melatonin secretion in
postmenopausal women with eating disorders. Endokrynol Pol.
;67(3):299-304. doi: 10.5603/ep.2016.0012
Ralston J, Brinsden H, Buse K, Candeias V, Caterson I,
Hassell T, et al. Time for a new obesity narrative. Lancet. 2018;
(10156):1384-6. doi: 10.1016/s0140-6736(18)32537-6
Morais TC, Honorio- Franca AC, Fujimori M, Quental OB,
Pessoa RS, França EL, et al. Melatonin action on the activity
of phagocytes from the colostrum of obese women. Medicina
(Kaunas) [Internet]. 2019[cited 2024 Feb 26];55(10):625. Available
from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843511/
pdf/medicina-55-00625.pdf doi: 10.3390/medicina55100625
Sieminski M, Szaruta- Raflesz K, Szypenbejl J, Krzyzaniak K.
Potential Neuroprotective Role of Melatonin in Sepsis- Associated
Encephalopathy Due to Its Scavenging and Anti- Oxidative
Properties. Antioxidants (Basel) [Internet]. 2023[cited 2024
Feb 23];12(9):1786. Available from: https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC10525116/pdf/antioxidants-12-01786.pdf
doi: 10.3390/antiox12091786
Ou TH, Tung YT, Yang TH, Chien YW. Melatonin improves
fatty liver syndrome by inhibiting the lipogenesis pathway in
hamsters with high-fat diet-induced hyperlipidemia. Nutrients
[Internet]. 2019[cited 2024 Feb 20];11(4):748. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520679/pdf/
nutrients-11-00748.pdf doi: 10.3390/nu11040748
Fernández Vázquez G, Reiter RJ, Agil A. Melatonin increases
brown adipose tissue mass and function in Zücker diabetic fatty
rats: implications for obesity control. J Pineal Res [Internet].
[cited 2024 Feb 23];64(4): e12472. Available from: https://
onlinelibrary.wiley.com/doi/10.1111/jpi.12472 doi: 10.1111/
jpi.12472
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2024 С.Б. Семененко, М.Д. Перепелюк, В.С. Джуряк, Н.Я. Черней, М.П. Мотрук
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Часопис користується «Типовим шаблоном положення про авторські права».
